DCF — CONDELL MEDICAL CENTER
Enterprise Value: $-54.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-54.1M
Enterprise Value
$-26.7M
PV of Cash Flows
$-27.4M
PV of Terminal Value
$-44.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $378.2M | $4.0M | 1.0% | $-12.0M | $-11.0M |
| Year 2 | $389.6M | $8.0M | 2.0% | $-8.5M | $-7.0M |
| Year 3 | $401.3M | $12.2M | 3.0% | $-5.3M | $-4.0M |
| Year 4 | $413.3M | $14.7M | 4.0% | $-3.9M | $-2.7M |
| Year 5 | $425.7M | $16.2M | 4.0% | $-3.2M | $-2.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-54.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$367.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.005475987831469774
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5